A simple pathway leading to 3-hydroxyquinoline-4(1 H )-one-5-carboxamides was developed. Target compounds were identified as potential anticancer agents and fluorescent labels.
No takes yet. Share an insight, caveat, or question.
Funk et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: